| RS2525589542 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525589710 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525589787 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Encephalopathy |
| RS2525589800 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525589804 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525589811 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525589836 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS2525589888 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525589981 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525590120 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525590337 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525590396 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525590698 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525590777 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS2525592797 |
GLUL
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 16 |
| RS2525596168 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525596224 |
CPT2
|
Health Risk |
Pathogenic |
CPT2-related disorder, Carnitine palmitoyltransferase II deficiency |
| RS2525596432 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS2525596435 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS2525596685 |
CPT2
|
Health Risk |
Likely pathogenic |
Encephalopathy, acute |
| RS2525599583 |
ATF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 7, Achromatopsia 7 |
| RS2525604589 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525608577 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525608929 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525609038 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525609231 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525609308 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Glioma susceptibility 1 |
| RS2525609335 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525609535 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525614292 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525614650 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525615664 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525620171 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2525628302 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525630257 |
RORC
|
Health Risk |
Pathogenic |
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency, Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency |
| RS2525635575 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525636128 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525636733 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525639606 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525639882 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525640747 |
GABRD
|
Health Risk |
Likely pathogenic |
GABRD-Related Disorders, Epilepsy |
| RS2525643959 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525644032 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525644185 |
GABRD
|
Health Risk |
Likely pathogenic |
Idiopathic generalized epilepsy, Idiopathic generalized epilepsy |
| RS2525644388 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525647407 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525648200 |
ASH1L
|
Health Risk |
Likely pathogenic |
— |
| RS2525648201 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525648243 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525652568 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525652620 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525652858 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525654022 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2525654508 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525656325 |
ACBD6
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with progressive movement abnormalities, Neurodevelopmental disorder with progressive movement abnormalities |
| RS2525659893 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525660178 |
NTRK1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2525660364 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525667534 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS2525667554 |
NTRK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Hereditary insensitivity to pain with anhidrosis |
| RS2525670078 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2525670965 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2525680353 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2525696069 |
KCND3
|
Health Risk |
Likely pathogenic |
— |
| RS2525697053 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2525698694 |
ACADM
|
Health Risk |
Likely pathogenic |
ACADM-related disorder, ACADM-related disorder |
| RS2525698722 |
KCND3
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2525698838 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525698959 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525698997 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699215 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699283 |
KCND3
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS2525699415 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699516 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699682 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699762 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699778 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699808 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699882 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525699893 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525706560 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525706737 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525706749 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525706798 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525706932 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525706936 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2525709329 |
NDUFS2
|
Health Risk |
Likely pathogenic |
— |
| RS2525716351 |
CKS1B;SHC1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS2525716661 |
CKS1B;LOC129931529;SHC1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS2525724749 |
ARID1A
|
Health Risk |
Pathogenic |
— |
| RS2525730822 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525736683 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2525744586 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS2525744746 |
DMD
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2525749949 |
HJV
|
Health Risk |
Pathogenic |
— |
| RS2525753200 |
ASH1L
|
Health Risk |
Likely pathogenic |
ASH1L-related disorder, ASH1L-related disorder |
| RS2525756260 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS2525759209 |
APOA2
|
Health Risk |
Likely pathogenic |
— |
| RS2525771157 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS2525791495 |
FLAD1
|
Health Risk |
Likely pathogenic |
— |